China Aoxing Pharmaceutical Company to Present at 2009 China Growth Conference of Adam Friedman Associates on October 28, 2009
19 Ottobre 2009 - 3:28PM
PR Newswire (US)
NEW YORK, Oct. 19 /PRNewswire-FirstCall/ -- China Aoxing
Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a
China-based pharmaceutical company specializing in research,
development, manufacturing and distribution of narcotic and
pain-management products, today announced that the Company will
present at the 2009 China Growth Conference on October 28, 2009.
The conference is organized by Adam Friedman Associates at
Princeton Club of New York. Management will meet with institutional
investors throughout the conference. For further details, please
contact your institutional sales representative. About China Aoxing
Pharmaceutical Company, Inc. China Aoxing Pharmaceutical Company,
Inc. (OTCBB: CAXG) is a pharmaceutical company located in China
specializing in research, development, manufacturing and
distribution of a variety of narcotics and pain-management
products. It has a strategic alliance with American Oriental
Bioengineering, Inc. (NYSE:AOB) to develop and market various
narcotic drugs in China. Headquartered in Shijiazhuang City, the
pharmaceutical capital of China, outside of Beijing, China Aoxing
has China's largest and the most advanced manufacturing facility
for highly regulated narcotic medicines, addressing a very
under-served and fast-growing market in China. Its facility is one
of the few GMP facilities licensed for narcotics medicines. The
Company is working closely with the Chinese government and SFDA to
assure the strictly regulated availability to medical professionals
of its narcotic drugs and pain medicines throughout China.
Statements made in this press release are forward-looking and are
made pursuant to the safe harbor provisions of the Securities
Litigation Reform Act of 1995. Such statements involve risks and
uncertainties that may cause actual results to differ materially
from those set forth in these statements. The economic,
competitive, governmental, technological and other risk factors
identified in the Company's filings with the Securities and
Exchange Commission, including the Form 10-KSB for the year ended
June 30, 2008, may cause actual results or events to differ
materially from those described in the forward looking statements
in this press release. The Company undertakes no obligation to
publicly update or revise any forward-looking statements, whether
because of new information, future events, or otherwise.
DATASOURCE: China Aoxing Pharmaceutical Company, Inc. CONTACT: Wei
Zhang, China Aoxing Pharmaceutical Company, Inc., Email: ,
Telephone: (646) 367-1747, Website: http://www.chinapainmed.com/
Copyright